# Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.

> **NCT02759991** · PHASE4 · COMPLETED · sponsor: **Norwegian Institute of Public Health** · enrollment: 19460 (actual)

## Conditions studied

- Hepatitis E Infection

## Interventions

- **DRUG:** Hecolin
- **DRUG:** Hepa-B

## Key facts

- **NCT ID:** NCT02759991
- **Lead sponsor:** Norwegian Institute of Public Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-02
- **Primary completion:** 2019-09-30
- **Final completion:** 2019-09-30
- **Target enrollment:** 19460 (ACTUAL)
- **Last updated:** 2024-08-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02759991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02759991, "Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02759991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*